AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34039390 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital intervention for managing uncontrolled hypertension
Number of subjects: 125
Study 34920045 — intervention group
Group type: COMPARATOR
Intervention: SGLT2 inhibitors
Number of subjects: 71545
Study 32183779 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention to improve pediatric HIV care cascade focusing on patient tracking, active follow-up of defaulting patients, reduction in EID turn-around times for PCR results, and initiation of ART by nurses in child-at-risk services.
Number of subjects: 0
Study 35666375 — intervention group
Group type: EXPERIMENTAL
Intervention: PDT with 0.01% methylene blue photosensitizer/therapeutic laser-InGaAIP before PDT (Group 1)
Number of subjects: 54
Study 35666375 — intervention group
Group type: EXPERIMENTAL
Intervention: PDT with 0.01% methylene blue photosensitizer/therapeutic laser-InGaAIP 1 min after PDT (Group 2)
Number of subjects: 54
Study 35666375 — intervention group
Group type: EXPERIMENTAL
Intervention: PDT with 0.01% methylene blue photosensitizer/therapeutic laser-InGaAIP before PDT (Group 3)
Number of subjects: 54
Study 35666375 — intervention group
Group type: EXPERIMENTAL
Intervention: PDT with 0.01% methylene blue photosensitizer/therapeutic laser-InGaAIP 5 min after PDT (Group 4)
Number of subjects: 54
Study 32256020 — intervention group
Group type: COMPARATOR
Intervention: rs111686806 in the HLA-A gene
Number of subjects: 382
Study 32256020 — intervention group
Group type: COMPARATOR
Intervention: rs1055348 in the HLA-B gene
Number of subjects: 382
Study 32256020 — intervention group
Group type: COMPARATOR
Intervention: rs202047044 in the HLA-DRB1 gene
Number of subjects: 382
Study 32256020 — intervention group
Group type: EXPERIMENTAL
Intervention: HLA-B*35:01
Number of subjects: 382
Study 33219694 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab (ADA)
Number of subjects: 487
Study 33219694 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab (INF)
Number of subjects: 487
Study 33219694 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept (ETA)
Number of subjects: 487
Study 33044249 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic pure PRP injection (4 mL)
Number of subjects: 60
Study 33044249 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroid injection (4 mL mixture of 1 mL of 40‐mg/mL triamcinolone acetonide and 3 mL of 2% lidocaine)
Number of subjects: 60
Study 33044249 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroid injection (4 mL mixture)
Number of subjects: 60
Study 35322520 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment
Number of subjects: 0
Study 35322520 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32281082 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (9 weeks)
Number of subjects: 66
Study 32281082 — intervention group
Group type: COMPARATOR
Intervention: Routine diabetes care (control group)
Number of subjects: 66
Study 35481725 — intervention group
Group type: EXPERIMENTAL
Intervention: Executive Function (EF) training
Number of subjects: 70
Study 33922552 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitoring depth of anesthesia using Entropy and Surgical Pleth Index (SPI) values
Number of subjects: 95
Study 33922552 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 95
Study 33922552 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl administration
Number of subjects: 95
Study 33922552 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane administration
Number of subjects: 95
Study 33922552 — intervention group
Group type: EXPERIMENTAL
Intervention: Noradrenaline administration
Number of subjects: 95
Study 34255767 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment based on cerebrospinal fluid (CSF) analysis after lumbar puncture (LP)
Number of subjects: 96
Study 34255767 — intervention group
Group type: COMPARATOR
Intervention: No lumbar puncture (LP)
Number of subjects: 96
Study 35007642 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical exercise program (3-4 times per week for 6 weeks, total 20 hours)
Number of subjects: 52
Study 35007642 — intervention group
Group type: COMPARATOR
Intervention: Control program
Number of subjects: 52
Study 33685394 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical tissue adhesive (TA)
Number of subjects: 150
Study 33685394 — intervention group
Group type: COMPARATOR
Intervention: Standard control (SC)
Number of subjects: 150
Study 33331393 — intervention group
Group type: EXPERIMENTAL
Intervention: Autogenous bone graft (AB)
Number of subjects: 40
Study 33331393 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioactive glass (BG)
Number of subjects: 40
Study 33331393 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioactive glass + autogenous bone graft (BG + AB) 1:1
Number of subjects: 40
Study 33331393 — intervention group
Group type: EXPERIMENTAL
Intervention: Bio-Oss (BO)
Number of subjects: 40
Study 33331393 — intervention group
Group type: EXPERIMENTAL
Intervention: Bio-Oss + autogenous bone graft (BO + AB) 1:1
Number of subjects: 40
Study 36006686 — intervention group
Group type: EXPERIMENTAL
Intervention: Short web‐based educational intervention about SR methodology
Number of subjects: 589
Study 36006686 — intervention group
Group type: COMPARATOR
Intervention: PRISMA checklist
Number of subjects: 589
Study 32731764 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT‐I)
Number of subjects: 77
Study 32122147 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-exchange (WE) technique
Number of subjects: 46
Study 32122147 — intervention group
Group type: COMPARATOR
Intervention: Carbon dioxide (CO2) insufflation
Number of subjects: 46
Study 35671521 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote monitoring intervention
Number of subjects: 1500
Study 35671521 — intervention group
Group type: COMPARATOR
Intervention: Control group (test group itself)
Number of subjects: 1500
Study 35034023 — intervention group
Group type: EXPERIMENTAL
Intervention: Titration group (Adinox® 25 mg aspirin/200 mg dipyridamole once daily for 2 weeks, then twice daily for 2 weeks)
Number of subjects: 96
Study 35034023 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard group (Adinox® twice daily for 4 weeks)
Number of subjects: 96
Study 35034023 — intervention group
Group type: COMPARATOR
Intervention: Control group (Aspirin 100 mg once daily for 4 weeks)
Number of subjects: 96
Study 35034023 — intervention group
Group type: EXPERIMENTAL
Intervention: Titration group
Number of subjects: 96
Study 35034023 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard group
Number of subjects: 96
Study 32753348 — intervention group
Group type: EXPERIMENTAL
Intervention: [U13C]linoleate
Number of subjects: 24
Study 32753348 — intervention group
Group type: COMPARATOR
Intervention: [U13C]palmitate
Number of subjects: 24
Study 35768786 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayes‐theorem based risk prediction model implemented in hospitals
Number of subjects: 0
Study 34274108 — intervention group
Group type: EXPERIMENTAL
Intervention: dTMS
Number of subjects: 125
Study 34274108 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 125
Study 33534403 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 additional mastery level simulated performances
Number of subjects: 48
Study 33534403 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 additional mastery level simulated performances
Number of subjects: 48
Study 33534403 — intervention group
Group type: COMPARATOR
Intervention: 0 additional mastery level simulated performances (Control)
Number of subjects: 48
Study 33534403 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial assessment
Number of subjects: 48
Study 33534403 — intervention group
Group type: EXPERIMENTAL
Intervention: Retention assessment
Number of subjects: 48
Study 32108436 — intervention group
Group type: EXPERIMENTAL
Intervention: AbobotulinumtoxinA 1000 U
Number of subjects: 388
Study 32108436 — intervention group
Group type: EXPERIMENTAL
Intervention: AbobotulinumtoxinA 1500 U
Number of subjects: 388
Study 32108436 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 388
Study 33779360 — intervention group
Group type: EXPERIMENTAL
Intervention: PANSS‐6 ratings obtained via the SNAPSI
Number of subjects: 77
Study 33779360 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in PANSS‐6 total scores via the SNAPSI
Number of subjects: 77
Study 33075261 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor monotherapy
Number of subjects: 0
Study 33075261 — intervention group
Group type: COMPARATOR
Intervention: DAPT (Dual Antiplatelet Therapy)
Number of subjects: 0
Study 35762666 — intervention group
Group type: EXPERIMENTAL
Intervention: MM-SES-CD total score ≥26 at week 76
Number of subjects: 208
Study 35762666 — intervention group
Group type: EXPERIMENTAL
Intervention: Rutgeerts score at week 76
Number of subjects: 208
Study 35762666 — intervention group
Group type: EXPERIMENTAL
Intervention: SES-CD ileum score at week 76
Number of subjects: 208
Study 35762666 — intervention group
Group type: EXPERIMENTAL
Intervention: MM-SES-CD ileum score at week 76
Number of subjects: 208
Study 33675664 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin administration
Number of subjects: 45
Study 32524934 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothers' own high liking for sweet and savoury restricted foods and drinks
Number of subjects: 211
Study 32524934 — intervention group
Group type: EXPERIMENTAL
Intervention: Child high intake frequency at 5 years old
Number of subjects: 211
Study 32524934 — intervention group
Group type: EXPERIMENTAL
Intervention: Child early exposure
Number of subjects: 211
Study 34075476 — intervention group
Group type: EXPERIMENTAL
Intervention: INFANT intervention
Number of subjects: 262
Study 616063581 — intervention group
Group type: EXPERIMENTAL
Intervention: Neo dermal activator wound dressing
Number of subjects: 54
Study 616063581 — intervention group
Group type: COMPARATOR
Intervention: Preoperative chemotherapy
Number of subjects: 54
Study 36342435 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy intervention
Number of subjects: 150
Study 36342435 — intervention group
Group type: EXPERIMENTAL
Intervention: Misperceptions intervention
Number of subjects: 150
Study 36342435 — intervention group
Group type: COMPARATOR
Intervention: Empathetic listening control
Number of subjects: 150
Study 34113085 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic Blood Pressure (SBP)
Number of subjects: 2888
Study 34113085 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse Pressure (PP)
Number of subjects: 2888
Study 34113085 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean Arterial Pressure (MAP)
Number of subjects: 2888
Study 34113085 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse Pressure Index (PPI)
Number of subjects: 2888
Study 34113085 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolated abnormal SBP
Number of subjects: 2888
Study 34113085 — intervention group
Group type: EXPERIMENTAL
Intervention: PP ≥50 mmHg
Number of subjects: 2888
Study 32454920 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.5 μg/kg intravenous bolus injection for 10 min before induction of anesthesia, followed by continuous infusion of 0.2‐0.4 μg/kg/h until the end of surgery, and 0.06 μg/kg/h for 5 days after surgery)
Number of subjects: 62
Study 32454920 — intervention group
Group type: COMPARATOR
Intervention: Saline (equal volumes)
Number of subjects: 62
Study 32454920 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 62
Study 35612860 — intervention group
Group type: EXPERIMENTAL
Intervention: MORACS intervention (automatically triggered diagnostic support from tertiary hospital)
Number of subjects: 6249
Study 35612860 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 6249
Study 35612860 — intervention group
Group type: EXPERIMENTAL
Intervention: MORACS intervention
Number of subjects: 6249
Study 35612860 — intervention group
Group type: EXPERIMENTAL
Intervention: Missed STEMI diagnoses
Number of subjects: 6249
Study 35612860 — intervention group
Group type: EXPERIMENTAL
Intervention: Accurately diagnosed STEMI
Number of subjects: 6249
Study 35936363 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous psychological nursing based on grey clustering algorithm combined with pelvic floor muscle exercise
Number of subjects: 98
Study 35936363 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing (Control)
Number of subjects: 98
Study 33284535 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for predicting overall survival (OS)
Number of subjects: 2471
Study 33284535 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for predicting cancer-specific survival (CSS)
Number of subjects: 2471
Study 33284535 — intervention group
Group type: EXPERIMENTAL
Intervention: Calibration curves for nomogram models
Number of subjects: 2471
Study 33284535 — intervention group
Group type: EXPERIMENTAL
Intervention: ROC and DCA for nomogram performance
Number of subjects: 2471
Study 34580858 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrodissection
Number of subjects: 46
Study 34580858 — intervention group
Group type: COMPARATOR
Intervention: No hydrodissection (Control)
Number of subjects: 46
Study 33203618 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral beta blockade
Number of subjects: 3500
Study 33203618 — intervention group
Group type: EXPERIMENTAL
Intervention: ACEI/ARB
Number of subjects: 3500
Study 33203618 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta blocker and ACEI/ARB
Number of subjects: 3500
Study 33203618 — intervention group
Group type: COMPARATOR
Intervention: Neither ACEI/ARB nor beta blocker
Number of subjects: 3500
Study 32644891 — intervention group
Group type: EXPERIMENTAL
Intervention: MCPP appliances
Number of subjects: 39
Study 32644891 — intervention group
Group type: COMPARATOR
Intervention: GMD appliances
Number of subjects: 39
Study 34622344 — intervention group
Group type: EXPERIMENTAL
Intervention: rtfMRI neurofeedback (NF) training
Number of subjects: 52
Study 34622344 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 52
Study 33291229 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific Carbohydrate Diet (SCD)
Number of subjects: 18
Study 33291229 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Specific Carbohydrate Diet (MSCD)
Number of subjects: 18
Study 33291229 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole Foods Diet (WF)
Number of subjects: 18
Study 35040942 — intervention group
Group type: EXPERIMENTAL
Intervention: SRT (short-course radiotherapy of 5 × 5 Gy with surgery within 1 week)
Number of subjects: 840
Study 35040942 — intervention group
Group type: EXPERIMENTAL
Intervention: SRT-delay (short-course radiotherapy of 5 × 5 Gy with surgery after 4-8 weeks)
Number of subjects: 840
Study 35040942 — intervention group
Group type: EXPERIMENTAL
Intervention: LRT-delay (long-course radiotherapy of 25 × 2 Gy with surgery after 4-8 weeks)
Number of subjects: 840
Study 35040942 — intervention group
Group type: COMPARATOR
Intervention: SRT (short-course radiotherapy of 5 × 5 Gy)
Number of subjects: 840
Study 35040942 — intervention group
Group type: COMPARATOR
Intervention: SRT-delay (short-course radiotherapy of 5 × 5 Gy)
Number of subjects: 840
Study 35040942 — intervention group
Group type: COMPARATOR
Intervention: LRT-delay (long-course radiotherapy of 25 × 2 Gy)
Number of subjects: 840
Study 35040942 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment arms
Number of subjects: 840
Study 32800403 — intervention group
Group type: EXPERIMENTAL
Intervention: Polygonal template for intraoperative guidance
Number of subjects: 50
Study 34024196 — intervention group
Group type: EXPERIMENTAL
Intervention: Orchid drug-coated balloon (coated with paclitaxel)
Number of subjects: 60
Study 34024196 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous transluminal angioplasty
Number of subjects: 60
Study 34024196 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 60
Study 33985991 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumasiran (0.3-6 mg/kg single dose for healthy participants; up to 3 doses of 1 or 3 mg/kg monthly or 3 mg/kg quarterly for patients)
Number of subjects: 52
Study 33985991 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumasiran
Number of subjects: 52
Study 33985991 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 32746825 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialised palliative homecare (SPHC) support
Number of subjects: 1026
Study 32746825 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialised palliative homecare (SPHC) availability
Number of subjects: 1026
Study 32746825 — intervention group
Group type: EXPERIMENTAL
Intervention: Extent of engagement in palliative care
Number of subjects: 1026
Study 32746825 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of utilised SPHC
Number of subjects: 1026
Study 32746825 — intervention group
Group type: EXPERIMENTAL
Intervention: Involvement in treatment of palliative patients after SPHC initiation
Number of subjects: 1026
Study 32746825 — intervention group
Group type: EXPERIMENTAL
Intervention: Conviction that palliative care should be a central part of GPs' work
Number of subjects: 1026
Study 32746825 — intervention group
Group type: EXPERIMENTAL
Intervention: SPHC referrals
Number of subjects: 1026
Study 36301168 — intervention group
Group type: EXPERIMENTAL
Intervention: Fire needling group
Number of subjects: 66
Study 36301168 — intervention group
Group type: COMPARATOR
Intervention: Filiform needling group
Number of subjects: 66
Study 36301168 — intervention group
Group type: COMPARATOR
Intervention: Comparison between fire needling and filiform needling groups
Number of subjects: 66
Study 34338710 — intervention group
Group type: EXPERIMENTAL
Intervention: selfBACK app (tailored self-management support system)
Number of subjects: 461
Study 34338710 — intervention group
Group type: COMPARATOR
Intervention: usual care (control group)
Number of subjects: 461
Study 35708715 — intervention group
Group type: EXPERIMENTAL
Intervention: Alirocumab
Number of subjects: 17589
Study 35708715 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17589
Study 35708715 — intervention group
Group type: EXPERIMENTAL
Intervention: Ezetimibe (projected use)
Number of subjects: 17589
Study 34383537 — intervention group
Group type: EXPERIMENTAL
Intervention: DESTRESS-WV (online, coach-assisted cognitive behavioral intervention)
Number of subjects: 102
Study 34383537 — intervention group
Group type: EXPERIMENTAL
Intervention: DESTRESS-WV
Number of subjects: 102
Study 34383537 — intervention group
Group type: COMPARATOR
Intervention: Phone monitoring only
Number of subjects: 102
Study 35421127 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence to dietary counselling
Number of subjects: 602
Study 35421127 — intervention group
Group type: EXPERIMENTAL
Intervention: Food security status
Number of subjects: 602
Study 35421127 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity
Number of subjects: 602
Study 35421127 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes knowledge
Number of subjects: 602
Study 35421127 — intervention group
Group type: EXPERIMENTAL
Intervention: Lack of access to information
Number of subjects: 602
Study 35421127 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderately food insecure
Number of subjects: 602
Study 35421127 — intervention group
Group type: EXPERIMENTAL
Intervention: Severely food insecure
Number of subjects: 602
Study 33810477 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation focused on sustained attention through the NeuronUP platform, 3 days a week for 4 weeks
Number of subjects: 100
Study 33810477 — intervention group
Group type: COMPARATOR
Intervention: Control group (no therapy)
Number of subjects: 100
Study 32487592 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation of dehydration evidence-based guidelines (EBG)
Number of subjects: 7145
Study 35440358 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Therapy for Suicide Prevention (CTSP) + Treatment as Usual (TAU)
Number of subjects: 150
Study 35440358 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU) alone
Number of subjects: 150
Study 34992754 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive-behavioural grief therapy (ICBGT)
Number of subjects: 58
Study 34992754 — intervention group
Group type: COMPARATOR
Intervention: Waitlist-control group (WCG)
Number of subjects: 58
Study 32967883 — intervention group
Group type: EXPERIMENTAL
Intervention: SBRT with atezolizumab
Number of subjects: 103
Study 32967883 — intervention group
Group type: COMPARATOR
Intervention: SBRT alone
Number of subjects: 103
Study 34736438 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine with intravenous S-ketamine
Number of subjects: 80
Study 34736438 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine only
Number of subjects: 80
Study 32074702 — intervention group
Group type: EXPERIMENTAL
Intervention: Health belief model-based health education intervention (3 lectures of 20-30 min each)
Number of subjects: 400
Study 32074702 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 400
Study 32074702 — intervention group
Group type: EXPERIMENTAL
Intervention: Health belief model-based health education intervention
Number of subjects: 400
Study 35300564 — intervention group
Group type: EXPERIMENTAL
Intervention: Lacticaseibacillus paracasei N1115 (2×10^10 cfu/g, 2 g/day)
Number of subjects: 101
Study 35300564 — intervention group
Group type: COMPARATOR
Intervention: Placebo (maltodextrin, 2 g/day)
Number of subjects: 101
Study 34102091 — intervention group
Group type: EXPERIMENTAL
Intervention: Feminine/communal video
Number of subjects: 482
Study 34102091 — intervention group
Group type: EXPERIMENTAL
Intervention: Masculine/agentic video
Number of subjects: 482
Study 34102091 — intervention group
Group type: COMPARATOR
Intervention: No video (no exposure)
Number of subjects: 482
Study 33036946 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure-Controlled Ventilation (PCV)
Number of subjects: 66
Study 33036946 — intervention group
Group type: COMPARATOR
Intervention: Volume-Controlled Ventilation (VCV)
Number of subjects: 66
Study 33036946 — intervention group
Group type: EXPERIMENTAL
Intervention: Both PCV and VCV
Number of subjects: 66
Study 35267032 — intervention group
Group type: EXPERIMENTAL
Intervention: Semistructured interviews with female chairs
Number of subjects: 20
Study 35267032 — intervention group
Group type: COMPARATOR
Intervention: Semistructured interviews with male chairs
Number of subjects: 20
Study 32993325 — intervention group
Group type: EXPERIMENTAL
Intervention: Plaster-of-Paris casts
Number of subjects: 46